EOC Pharma Group pulls in $32 mln Series B
China-based EOC Pharma Group, an oncology-focused development and commercialization company, has closed $32 million in Series B financing. Taikang Investment led the round with participation from Sequoia China and H&Q Asia Pacific.
7 November 2017•1 min read
